J Korean Med Sci.  2024 Jan;39(4):e19. 10.3346/jkms.2024.39.e19.

Clinical Features of Mpox Patients in Korea: A Multicenter Retrospective Study

• Lim SY
• Jo HJ
• Lee SY
• Ahn M
• Kim Y
• Jeon J
• Kim ES
• Chin B
• Choi JP
• Kim NJ

• KMID: 2551962
• DOI: http://doi.org/10.3346/jkms.2024.39.e19

Abstract

Background
Mpox is a viral illness with a characteristic skin rash caused by the monkeypox virus. In 2022, Mpox spread throughout the world, and an epidemic through domestic transmission started in South Korea in early 2023. This study aimed to summarize the clinical features of Mpox patients in South Korea.
Methods
This is a multicenter retrospective study conducted at four hospitals in South Korea. All adult patients diagnosed with Mpox who were admitted to the study hospitals between June 1, 2022 and May 26, 2023 and were discharged by June 30, 2023 were reviewed.
Results
Sixty patients were included, accounting for 65.9% of Mpox cases reported in South Korea during the study period. Median age was 32 years and 97% (58/60) of patients were male. In total, 85% (51/60) of patients reported their sexual orientation as homosexual or bisexual. The most common route of transmission was sexual or close contact (55/60). Every patient had a skin rash and 88% (53/60) had constitutional symptoms. In total, 42% (25/60) of patients had human immunodeficiency virus and 25% (15/60) had concomitant sexually transmitted infections. Severe manifestations of Mpox were identified in only two patients.
Conclusion
Mpox patients in South Korea were mainly young adult males and were infected through sexual contact. The clinical outcomes were favorable.

Keyword

Mpox; Monkeypox; South Korea; Korea

Figure

• 

  Fig. 1 Temporal changes in typical skin lesions. (A) Maculopapular rash. (B) Vesiculopustular. (C) Crust-forming.

Reference

1. Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med. 2022; 387(19):1783–1793. PMID: 36286263.

2. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972; 46(5):593–597. PMID: 4340218.

3. Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. Lancet. 2023; 401(10370):60–74. PMID: 36403582.

4. World Health Organization. Mpox (monkeypox) outbreak 2022. Updated 2022. Accessed August 20, 2023. https://www.who.int/emergencies/situations/monkeypox-oubreak-2022 .

5. Jang YR, Lee M, Shin H, Kim JW, Choi MM, Kim YM, et al. The first case of monkeypox in the Republic of Korea. J Korean Med Sci. 2022; 37(27):e224. PMID: 35818706.

6. Korea Disease Control and Prevention Agency. Mpox outbreak status in Korea. Updated 2023. Accessed August 20, 2023. https://www.kdca.go.kr/contents.es?mid=a20108080000 .

7. Choi Y, Jeon EB, Kim T, Choi SJ, Moon SM, Song KH, et al. Case report and literature review of occupational transmission of monkeypox virus to healthcare workers, South Korea. Emerg Infect Dis. 2023; 29(5):997–1001. PMID: 36856759.

8. Kim T, Park E, Eun JS, Lee EY, Mun JW, Choi Y, et al. Detecting Mpox infection in the early epidemic: an epidemiologic investigation of the third and fourth cases in Korea. Epidemiol Health. 2023; 45:e2023040. PMID: 36996865.

9. Yim HS, Um J, Kim HS, Jeon J, Kim JS, Choi JP, et al. A case of human Mpox with isolated perianal ulcers development in convalescent phase. Infect Chemother. 2023; 55(1):128–132. PMID: 37021428.

10. Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, et al. Severe monkeypox in hospitalized patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022; 71(44):1412–1417. PMID: 36327164.

11. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022; 387(8):679–691. PMID: 35866746.

12. Maldonado-Barrueco A, Sanz-González C, Gutiérrez-Arroyo A, Grandioso-Vas D, Roces-Álvarez P, Sendagorta-Cudos E, et al. Sexually transmitted infections and clinical features in monkeypox (Mpox) patients in Madrid, Spain. Travel Med Infect Dis. 2023; 52:102544. PMID: 36669636.

13. Pourriyahi H, Aryanian Z, Afshar ZM, Goodarzi A. A systematic review and clinical atlas on mucocutaneous presentations of the current monkeypox outbreak: with a comprehensive approach to all dermatologic and nondermatologic aspects of the new and previous monkeypox outbreaks. J Med Virol. 2023; 95(2):e28230. PMID: 36254380.

14. Eisenstadt R, Liszewski WJ, Nguyen CV. Recognizing minimal cutaneous involvement or systemic symptoms in monkeypox. JAMA Dermatol. 2022; 158(12):1457–1458. PMID: 36201177.

15. Okoli GN, Van Caeseele P, Askin N, Abou-Setta AM. Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous Mpox outbreaks: a rapid review and meta-analysis. Infect Dis (Lond). 2023; 55(7):490–508. PMID: 37200216.

16. León-Figueroa DA, Barboza JJ, Saldaña-Cumpa HM, Moreno-Ramos E, Bonilla-Aldana DK, Valladares-Garrido MJ, et al. Detection of monkeypox virus according to the collection site of samples from confirmed cases: a systematic review. Trop Med Infect Dis. 2022; 8(1):4. PMID: 36668911.

17. Angelo KM, Smith T, Camprubí-Ferrer D, Balerdi-Sarasola L, Díaz Menéndez M, Servera-Negre G, et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2023; 23(2):196–206. PMID: 36216018.

18. Korea Disease Control and Prevention Agency. Guidelines on response to monkeypox. 5th ed. Updated 2023. Accessed October 22, 2023. https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019 (for local government).